Canady Helios Cold Plasma (CHCP) Ablation System
Ablation of soft tissue during surgery (Oncology)
ApprovedActive
Key Facts
Indication
Ablation of soft tissue during surgery (Oncology)
Phase
Approved
Status
Active
Company
About US Medical Innovations
US Medical Innovations is a private medical device company pioneering cold atmospheric plasma technology for intraoperative cancer treatment. The company has achieved significant regulatory milestones, including FDA 510(k) clearance for its Canady Helios Cold Plasma Ablation System and FDA approval for a robotic surgical wrist device. Led by founder and CEO Dr. Jerome Canady, USMI is advancing a platform that aims to treat inoperable and advanced solid tumors, with early clinical data published from a Phase 1 trial.
View full company profile